Treatment that can double bladder cancer survival rates available to 1,000 patients in England
In England, 18,000 people are diagnosed with bladder cancer each year, and only about 10% of people with stage 4 bladder cancer will survive five years or more after they are diagnosed.
The treatment, enfortumab vedotin with pembrolizumab, has been approved for use on the NHS from Thursday. About 1,250 patients across the country to be offered the therapy, which has been described by NHS bosses as one of the 'most hopeful advances in decades'.
Clinical trials of the drug have shown that people with bladder cancer that has spread (metastasised) live up to twice as long when given the combination antibody treatment when compared with those given normal chemotherapy.
One trial also found that almost 30% of patients had no detectable traces of cancer in their body following treatment with enfortumab vedotin and pembrolizumab, compared with only 12.5% with chemotherapy.
Prof Peter Johnson, NHS England's national clinical director for cancer, said that the treatment is 'one of the most hopeful advances in decades for people with bladder cancer'.
He added: 'Bladder cancer is often difficult to treat once it has spread, but this new therapy is the first one in years to really help stop the disease in its tracks, and our rollout to NHS patients will make a huge difference to the lives of those affected and their families.'
The therapy works by enfortumab vedotin directly targeting the cancer cells and killing them, while pembrolizumab, an immunotherapy drug, helps the immune system recognise and fight the remaining cancer cells.
Life expectancy for people with bladder cancer which has metastasised is usually only just over a year, but this new therapy increased survival for people with this stage of the disease by more than one year.
Jeannie Rigby, the chief executive of Action Bladder Cancer UK, said the charity, 'bladder cancer patients and their families welcome this much-needed, step forward in treatments available for this hard-to-treat cancer.
'This new drug has the potential to increase how long people have before their cancer gets worse and how long they live compared with the current, limited, treatment choices available. It's also of importance that this treatment can mean these patients can experience a better quality of life with less hard to tolerate side effects.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
33 minutes ago
- The Independent
Not drinking enough water causes greater biological response to stress
People who do not drink enough water have a stronger biological response to stress, according to a study. Researchers found those who habitually drink less release greater levels of the stress hormone cortisol, despite not feeling any thirstier than people who drink more. Keeping a water bottle nearby during stressful periods could be beneficial for long-term health, researchers suggest. The study, led by experts at Liverpool John Moores University (LJMU), included 16 people who drank under 1.5 litres of water a day, along with 16 people who regularly met daily recommended guidelines for fluid intake. Researchers used the European Food Safety Authority (EFSA) guidelines, which recommends men should drink 2.5 litres of water a day while women should drink two litres. In the UK, the Eatwell Guide suggests adults should drink between six and eight cups of fluid a day, which is roughly 1.5 to two litres. However, people may need to drink more when it is hot, if they are very active, if they are recovering from an illness, or if they are pregnant or breastfeeding. Researchers monitored hydration in both groups over seven days using urine and blood samples, after which they were invited into the lab for a stress test. The test involved an impromptu job interview, for which each individual was given 10 minutes to prepare for. After that time, they were invited into another room where a fake camera was set up and asked to do the interview to a panel of three people dressed in white coats. Following the fake interview, individuals were then asked to do a mental arithmetic challenge which involved subtracting numbers as fast as they can. Professor Neil Walsh, of the LJMU School of Sport and Exercise Sciences, described the test as 'really flustering'. He told the PA news agency: 'We know that people who have a low daily fluid intake, who don't meet the recommendations, are likely to be poorly hydrated. 'But what we didn't know was whether, when you then stress those people under controlled conditions, they would have a greater stress hormone response.' Researchers collected saliva samples from the group before and after the stress test to measure cortisol levels. Cortisol, known as the stress hormone, is produced by the adrenal glands in response to stress and also plays a role in immune response, metabolism and blood pressure. The team found cortisol levels were higher in those who drank less. Prof Shaw noted that stress responses such as increased heart rate, sweaty hands and dry mouth were similar between the two groups. 'Both groups felt equally anxious and experienced similar increases in heart rate during the stress test,' he said. 'But the people who were poorly hydrated, because they were not drinking enough water each day, had much greater cortisol responses.' The low-fluid intake group did also not report feeling more thirsty than those who drank more, according to Prof Walsh. He added: 'Cortisol is the body's primary stress hormone and exaggerated cortisol reactivity to stress is associated with an increased risk of heart disease, diabetes and depression. 'If you know you have a looming deadline or a speech to make, keeping a water bottle close could be a good habit with potential benefits for your long-term health.' Prof Walsh said further research is needed to better understand the findings, published in the Journal of Applied Physiology, and to see if increasing water intake in those who do not drink enough can reduce responses to daily 'micro stressors' like traffic jams or presentations at work. 'We'd like to think that meeting the water intake guidelines could be one of a number of things you could do to blunt that cortisol response day to day,' he added.
The Independent
33 minutes ago
- The Independent
New software could reduce NHS waiting lists for prosthetic legs, study finds
New software which personalises prosthetic leg fittings based on data from previous patients could help reduce NHS waiting lists, a study has found. The data-driven fittings for below the knee prosthetics were, on average, as comfortable for patients as those created by highly skilled prosthetists, the NHS trial suggested. Technology developed by Radii Devices and the University of Southampton is hoping to halve the number of clinical visits for the fitting from an average of four to two using the software. The new technology is built to provide a personalised 'socket' using data from other fittings and a 3D scan of the residual limb to immediately generate a basic design. The CEO and founder of Radii Devices, Dr Joshua Steer, said analysing hundreds of previous sockets allowed them to 'identify trends' between different patient characteristics. 'We can then scan a new patient's residual limb and generate a personalised design recommendation based on features that have been successful for similar patients in the past,' he explained. The results of an NHS trial published on Friday in JMIR Rehabilitation and Assistive Technology suggest the new designs are on average as comfortable as those created by a prosthetist. Nineteen sockets were made for 17 participants, as two participants were double amputees, and all bar one of the sockets were above the 'NHS comfort score target', the Radii Devices CEO said. Of those 19 sockets, six of the new designs were reportedly more comfortable than normal prosthetics, while five were less and eight were very similar. Prosthetic sockets are personalised to ensure they are comfortable and functional, as they need to bear a person's body weight without damaging limb tissue or creating discomfort. Traditionally, a prosthetist makes a plaster cast of the leg and reshapes it to produce a socket which achieves the right balance, producing trial versions before settling on a definitive one. Radii Devices says the NHS currently tries to deliver a prosthetic in four clinical visits roughly a month from their first appointment, while the new system can aim for a 'gold standard' of two appointments. Alex Dickinson, Professor of Prosthetics Engineering at the University of Southampton – who helped to develop the new method, acknowledges that it has limits. He said: 'Only a highly skilled prosthetist can identify things like bone spurs and neuromas, and know how to tweak designs to avoid causing pain or damage at these sensitive areas. 'We developed the data-driven socket design approach to save prosthetists' time by giving them a solid base to work from so they can use their expertise where it is most valuable, in making precise adaptations tailored to their patients' specific needs. 'The method effectively helps prosthetists to learn from each other.' Another co-author, Professor Maggie Donovan-Hall, said it was 'surprising and encouraging' that the data-driven sockets performed so well in a test designed as a 'worst case' scenario where they received no additional input from prosthetists. Nearly 100 people have now had a prosthetic leg designed this way, across multiple centres in the UK and the USA. The study has now moved into its final stage where the new software is developed alongside clinicians to see how it can be best incorporated into their practices.
The Independent
33 minutes ago
- The Independent
9 in 10 shoppers call for healthy food to be more affordable despite sales of junk food falling
Legislation to restrict supermarket sales of junk food has led to a 'significant' reduction in purchases, according to the first ever independent analysis. The research, which was carried out in England by the University of Leeds, estimates that two million fewer products high in fat, sugar or salt (HFSS) were sold per day after the new law took effect. The team analysed 11.6 billion items sold in Tesco, Morrisons, Sainsbury's and Asda. Before the legislation was implemented, 20 out of every 100 items sold were HFSS products that fell within the scope of the legislation. This number dropped to 19 after the legislation, which restricts the location of HFSS products within supermarkets in England as part of the UK Government's Childhood Obesity Strategy, was introduced in October 2022, the study found. Nearly 2,000 shoppers were also surveyed to find out how the legislation was perceived and how it affected their shopping behaviour. Although 73 per cent of shoppers did not think it would impact their own shopping behaviour, 71 per cent believed it would have more impact on others who did not plan their shopping. Nearly all shoppers (90 per cent) thought making healthier foods affordable was just as, if not more, important than the legislation against less healthy food. The study noted that the legislation was intended to go unnoticed and this was largely achieved, as 56 per cent of shoppers did not notice any changes in store. Professor Michelle Morris, who led the research team, said: 'Our research shows that the HFSS legislation was a force for good, leading to significant reduction in sales of in-scope HFSS products. 'But more now needs to be done to make healthy and sustainable diets the easy choice for our population, so that we can shift more people's eating habits towards the national recommendations of the Eatwell Guide.' Dr Alison Fildes, of the University of Leeds School of Psychology, said: 'Our findings suggested shoppers were in favour of the HFSS legislation. 'However, they also expressed their support for greater promotion and affordability of healthy foods. 'Tightening the current legislating to ensure HFSS products are replaced in prominent locations with healthier foods, would go further towards helping shoppers make healthier purchases.'
